Randomised Trial of Telehealth Consultations for Nursing Care of Chronic Obstructive Pulmonary Disease (COPD) Patients

Overview

The purpose of this study is to determine whether telehealth nursing consultations of chronic obstructive pulmonary disease (COPD) patients are superior to hospital readmissions.

Full Title of Study: “Effectiveness of Nurse Lead Telehealth Consultations in Patients With Chronic Obstructive Pulmonary Disease (COPD)”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: February 2012

Detailed Description

COPD is among the most common reasons for illness and fatality in adults worldwide, and it is expected that this trend will escalate radically by 2020 (1). Approximately 29% of patients admitted to Hospital with exacerbation will be readmitted within the first month (2), and after one year 46% of patients will have been readmitted on one or more occasions due to exacerbation (3). Therefore, trials have been carried out using different forms of digitally supported distance health interventions (telehealth nurse consultations) (4) of patients with COPD with a view to reducing the number of readmissions in a reliable way, measured in relation to mortality. Thus in these trials there are a certain indication that use of telehealth nurse consultations of patients with COPD is a treatment initiative that reliably can reduce the number of COPD patients readmitted with exacerbation. The number of randomized telehealth studies are however few (4;5), and there is a lack of documentation of the effect of telehealth monitoring. Therefore, a large randomized telehealth study with a clear set up was necessary. This study is a randomized multicenter trial that will take place at the acute admissions department and lung department at Odense University Hospital,Denmark We hypothesized that in a period of 26 weeks: 1. The total number of readmissions can be reduced with 14% 2. The time to the first readmission will be prolonged 3. The number of readmissions with exacerbation can be reduced after telehealth consultations as a supplement to the conventional treatment compared with conventional treatment 4. The total number of readmission days can be reduced after telehealth consultations as a supplement to the conventional treatment compared with conventional treatment 5. The total number of readmission days with exacerbation can be reduced after telehealth consultations as a supplement to the conventional treatment compared with conventional treatment 6. The mortality rate will remain unchanged after the telehealth consultations as a supplement to the conventional treatment compared with conventional treatment

Interventions

  • Behavioral: Telehealth consultation
    • The consultations are structured as outpatient sessions immediately after discharge. The content of the education deals with the regular treatment, prevention of exacerbation and how to live with the illness. The aim of the counseling is to increase the patient’s empowerment and competence to take action. The patients have the consultations for 7 days followed by a telephone call. Each session is organized and individualised according to the patient’s wishes and needs for education and counselling. The equipment consists of a computer with web camera, microphone and measurement equipment. A button to contact to the nurse at the hospital, an alarm button and a volume button. The results are transferred to the hospital by a secure internet line.

Arms, Groups and Cohorts

  • Experimental: Telehealth consultation
    • Telehealth nurse consultation plus treatment as usual
  • No Intervention: Conventional
    • Treatment as usual

Clinical Trial Outcome Measures

Primary Measures

  • The number of readmissions
    • Time Frame: at 26 weeks after discharge

Secondary Measures

  • The mortality rate
    • Time Frame: at 26 weeks weeks after discharge
  • The duration to the first readmission
    • Time Frame: at 26 weeks after discharge
  • The number of hospital readmissions with exacerbation
    • Time Frame: at 26 weeks after discharge
  • The number of days readmitted
    • Time Frame: days 26 weeks after discharge
  • The number of days readmitted with exacerbation
    • Time Frame: days 26 weeks after discharge

Participating in This Clinical Trial

Inclusion Criteria

  • Chronic obstructive pulmonary disease (COPD) verified by spirometry. – Exacerbation in COPD, defined as increased need for medicine, and increased dyspnea or increased expectorate or increased coughing. – > or 40 years old – Living on Funen and islands – Signed informed consent. Exclusion criteria:

  • Not able to communicate via telephone and/or computer screen – Previously received "The COPD suitcase", or participated in this protocol – Systolic BT is <100 mm Hg – Saturation < 90 – Thorax x-ray shows signs of malignant changes or lobar pneumonia – Diagnosed with cancer or recurrence of cancer within the last five years – Admitted with septic shock, acute myocardial infarction or other serious medical condition (for example renal disease) – Diagnosed with heart failure (EF < 30%) – Refused to participate

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Southern Denmark
  • Collaborator
    • Odense University Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Birte Oestergaard, Associate professor – University of Southern Denmark
  • Overall Official(s)
    • Anne Dichmann Sorknaes, PhD student, Principal Investigator, University of Southern Denmark

References

Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2.

(2) Sundhedsstyrelsen. Genindlæggelser af ældre i Danmark 2008 – Nye tal fra Sundhedsstyrelsen. 1060. Ref Type: Internet Communication.

Eriksen N, Hansen EF, Munch EP, Rasmussen FV, Vestbo J. [Chronic obstructive pulmonary disease. Admission, course and prognosis]. Ugeskr Laeger. 2003 Sep 8;165(37):3499-502. Danish.

Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, Alonso A, del Pozo F, de Toledo P, Anto JM, Rodriguez-Roisin R, Decramer M; members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006 Jul;28(1):123-30. doi: 10.1183/09031936.06.00063205. Epub 2006 Apr 12.

Finkelstein SM, Speedie SM, Potthoff S. Home telehealth improves clinical outcomes at lower cost for home healthcare. Telemed J E Health. 2006 Apr;12(2):128-36. doi: 10.1089/tmj.2006.12.128.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.